Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=63

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00249873-b165ea2a",
        "title": "Clopidogrel + ASA vs Placebo + ASA: Occurrence of Stroke",
        "summary": "296 of 3772 against 408 of 3782; risk difference -2.9 points, 95% interval -4.3 to -1.6; NCT00249873, Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)",
        "record": "/library/comparisons/NCT00249873-b165ea2a",
        "nct_id": "NCT00249873",
        "kind": "outcome",
        "participants": 7554,
        "risk_difference": {
          "value": -0.029406470230981946,
          "lower": -0.04253717951190418,
          "upper": -0.01631420746100238
        },
        "group_1": "296 of 3,772",
        "group_2": "408 of 3,782",
        "difference": "-2.9 points",
        "interval": "-4.3 to -1.6",
        "trial_title": "Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)"
      },
      {
        "id": "NCT00249873-sae",
        "title": "Clopidogrel + ASA vs Placebo + ASA: serious adverse events",
        "summary": "1154 of 3772 against 1069 of 3782; risk difference 2.3 points, 95% interval 0.3 to 4.4; NCT00249873, Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)",
        "record": "/library/comparisons/NCT00249873-sae",
        "nct_id": "NCT00249873",
        "kind": "serious-adverse-events",
        "participants": 7554,
        "risk_difference": {
          "value": 0.02328381410409186,
          "lower": 0.002729780002060988,
          "upper": 0.04381238197708376
        },
        "group_1": "1,154 of 3,772",
        "group_2": "1,069 of 3,782",
        "difference": "2.3 points",
        "interval": "0.3 to 4.4",
        "trial_title": "Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=64",
  "request_id": "uCfahnSB1j3pC7SR"
}